JD Vance Predicts: Wall Street vs. Trump & Your Money

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

Christian Vasquez net worth and biography

Christian Vasquez Biography and Net Worth

Insider of BioAtla

Mr. Vasquez has served as our Corporate Controller since November 2015, and as our VP of Finance since July 2020. Mr. Vasquez has over 20 years of Finance and business experience working with both public and private companies. He began his career with KPMG in their San Diego office’s audit practice. Prior to joining BioAtla, he served as an Associate Director of Accounting with Cricket Communications, a publicly-traded company that was acquired by AT&T. Throughout his career, Mr. Vasquez has held various accounting and finance positions of increasing responsibility. Mr. Vasquez received his BS degree in Accountancy from San Diego State University and is a Certified Public Accountant in the state of California.

What is Christian Vasquez's net worth?: The estimated net worth of Christian Vasquez is at least $160,226.04 as of March 28th, 2023. Mr. Vasquez owns 102,709 shares of BioAtla stock worth more than $160,226 as of November 17th. This net worth approximation does not reflect any other investments that Mr. Vasquez may own. Additionally, Mr. Vasquez receives an annual salary of $408,750.00 as Insider at BioAtla. Learn More about Christian Vasquez's net worth.
How old is Christian Vasquez?: Mr. Vasquez is currently 48 years old. There are 3 older executives and no younger executives at BioAtla. The oldest executive at BioAtla is Mr. Richard A. Waldron, Senior VP & CFO, who is 70 years old. Learn More on Christian Vasquez's age.
What is Christian Vasquez's salary?: As the Insider of BioAtla, Inc., Mr. Vasquez earns $408,750.00 per year. There are 3 executives that earn more than Mr. Vasquez. The highest earning executive at BioAtla is Dr. Jay M. Short Ph.D., Co-Founder, CEO & Chairman, who commands a salary of $1,130,000.00 per year. Learn More on Christian Vasquez's salary.
How do I contact Christian Vasquez?: The corporate mailing address for Mr. Vasquez and other BioAtla executives is , , . BioAtla can also be reached via phone at 858-558-0708 and via email at [email protected]. Learn More on Christian Vasquez's contact information.
Has Christian Vasquez been buying or selling shares of BioAtla?: Christian Vasquez has not been actively trading shares of BioAtla within the last three months. Most recently, on Tuesday, March 28th, Christian Vasquez bought 20,000 shares of BioAtla stock. The stock was acquired at an average cost of $2.40 per share, with a total value of $48,000.00. Following the completion of the transaction, the insider now directly owns 102,709 shares of the company's stock, valued at $246,501.60. Learn More on Christian Vasquez's trading history.
Who are BioAtla's active insiders?: BioAtla's insider roster includes Guy Levy (Director), Jay Short (CEO), Eric Sievers (Insider), Scott Smith (President), Lawrence Steinman (Director), Christian Vasquez (Insider), and Richard Waldron (CFO). Learn More on BioAtla's active insiders.
Are insiders buying or selling shares of BioAtla?: During the last year, BioAtla insiders bought shares 3 times. They purchased a total of 74,000 shares worth more than $157,320.00. The most recent insider tranaction occured on December, 26th when Director Sylvia Mcbrinn bought 4,000 shares worth more than $9,320.00. Insiders at BioAtla own 11.5% of the company. Learn More about insider trades at BioAtla.
Information on this page was last updated on 12/26/2023.

Christian Vasquez Insider Trading History at BioAtla

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/28/2023	Buy	20,000	$2.40	$48,000.00	102,709
6/9/2022	Buy	10,000	$2.97	$29,700.00	74,525
6/7/2022	Buy	14,152	$3.04	$43,022.08	38,677
12/1/2021	Sell	1,011	$23.04	$23,293.44
11/29/2021	Sell	642	$23.89	$15,337.38
11/24/2021	Sell	750	$24.87	$18,652.50
11/22/2021	Sell	691	$26.23	$18,124.93

Christian Vasquez Buying and Selling Activity at BioAtla

BioAtla Company Overview

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC), which is in Phase II clinical trial for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC that is in Phase II clinical trial for the treatment of melanoma and squamous cell cancer of the head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody, which is in Phase II clinical trial for treating melanoma, carcinomas, and NSCLC; and BA3182, a bispecific candidate that is in Phase 1 study for the treatment of adenocarcinomas, as well as BA3361, which is in preclinical studies for treating multiple tumor types. The company was founded in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $1.56

$1.50

$1.78

50 Day Range

MA: $1.91

$1.56

$2.37

2 Week Range

Now: $1.56

$1.14

$4.02

Volume

1,731,468 shs

Average Volume

993,847 shs

Market Capitalization

$75.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

JD Vance Predicts: Wall Street vs. Trump & Your Money

From Priority Gold | Ad

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

Christian Vasquez Biography and Net Worth

What is Christian Vasquez's net worth?

How old is Christian Vasquez?

What is Christian Vasquez's salary?

How do I contact Christian Vasquez?

Has Christian Vasquez been buying or selling shares of BioAtla?

Who are BioAtla's active insiders?

Are insiders buying or selling shares of BioAtla?